Stay updated on Dauno/Cytarabine ± Uproleselan in AML Clinical Trial
Sign up to get notified when there's something new on the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page.

Latest updates to the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.3.2 has been added as the latest entry and Revision: v3.2.0 has been removed from the history.SummaryDifference0.0%

- Check27 days agoChange DetectedDeleted an administrative banner about government funding status and NIH operating status from the page. This change does not affect core study information or how users interact with the page.SummaryDifference0.1%

- Check42 days agoChange DetectedThe history now includes entries for 2025-10-28 and 2025-10-29, and 2025-10-09 was removed; this change only updates the record history UI rather than the trial data or status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdditions introduce a new study-related entry and dates; deletions remove an earlier date. Net effect: page gains substantive study content and a new timestamp while an older date is removed.SummaryDifference0.4%

- Check70 days agoChange DetectedAdditions introduce a government operating-status notice and a new version (v3.2.0); deletions remove the previous version (v3.1.0) and an older date marker. Overall, the page now reflects current operating status and the latest revision.SummaryDifference4%

- Check78 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0; no other content or pricing/availability changes detected.SummaryDifference0.1%

Stay in the know with updates to Dauno/Cytarabine ± Uproleselan in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page.